# LLM call: summary

- Turn: 4
- Sequence: 11
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 774
- Completion tokens: 354
- Total tokens: 1241
- Cost (USD): 0.000149

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1361: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Autumn 2027 brought a claimed success and two shocks. The power/ports/water hardening drive formally completed in December: large transmission operators reported faster isolation and new detection stacks, though small utilities lagged from staff shortages and tuning remained incomplete.

The hospital forgery crisis deepened, with forensics confirming fabricated trials and insurance claims built with open models, fraud cases in three states, and warnings poisoned imaging could still pass checks.

A genome modelling paper then claimed model assistance could let a non-expert workflow design a viable human-infecting organism; methodologists called it alarmist and reckless, but health officials treated it as a step-change after the hospital fakes.

The Commission responded on two tracks: winter priority to scale up swarm-defence with top-up co-financing for small operators accepting mutual-aid teams and replay exercises for large grid firms to fix legacy clashes — rollout accelerated but uneven with hunters stretched; and a clinical-bio shield with standing hospital audits, pilot DNA-synthesis customer screening, and sequencing hubs tied to the disease control agency, framed by public-sector AI pilots cutting waiting lists. Gigafactories and sovereignty package remained paper-only site lists, contrasted with working sensors.

CURRENT NARRATIVE:
### The weights that would not come back
The first half of 2028 was dominated by a release no one in Brussels could recall. A frontier-class open-weight system appeared within months of the closed cutting edge, matching multi-hour coding and research work and showing real uplift on bio-design and offensive cyber benchmarks. Hundreds of thousands of downloads in the first week put it on private servers across Europe permanently. Ministers stopped talking about containment and started talking about catching the next one.

The Commission answered by tabling a proposal for an evaluation brake under existing AI Act powers: a planned vetted cell in the AI Office with compute access, third-party test mandates for models seeking EU deployment, and draft intolerable-risk thresholds for bio-design and autonomous cyber. No new operational capacity was created this turn. Staffing was not yet funded, legal services flagged pushback from developers over mandates, and coordination with third-party testers remained at scoping stage. No shadow tests were conducted and no thresholds were published; full effect awaits a future turn after proposal, staffing and legal clearance.

Priority stayed with health. Audit teams remained embedded in the three hospital networks hit by forged trials and insurance claims, prosecutors widened fraud files, and radiologists warned poisoned imaging sets still passed routine checks. The DNA-synthesis customer-screening pilot was tightened into a de facto licence condition through national ministries, and two sequencing hubs began joint exercises with the disease agency. Public pilots cutting waiting lists were showcased to hold licence, but fraud coverage soured the mood and cost political capital.

Swarm-defence co-financing continued without extra push: small operators accepted mutual-aid hunter teams, large grid firms missed replay deadlines, hunters stayed stretched. Gigafactories and the wider technology package remained permitting maps and site lists, continuing the portfolio drag on capital. Opposition press contrasted working sensors with paper factories, but there was no institutional break or treaty rejection — capital eroded under sustained delivery pressure, in line with ongoing charges, not a collapse.

In journals, whispers grew of editors quietly holding back AI-assisted clinical papers while forensic tools were checked — nothing announced, only delayed decisions and rumours of frozen approvals.
```

## Raw response

```
Autumn 2027 to mid-2028 saw hardening gains overtaken by forgery, bio-risk claims, and an uncontainable open release.

Power/ports/water hardening completed Dec 2027 with faster isolation and new detection at large operators, but small utilities lagged and tuning was incomplete. Swarm-defence top-up co-financing continued into 2028: small operators accepted mutual-aid hunters, large grid firms missed replay deadlines, hunters stayed stretched.

Hospital forgery crisis deepened: fabricated trials and insurance claims with open models, fraud cases in three states, poisoned imaging still passing checks. Commission kept health priority: audits embedded in three networks, fraud files widened, DNA-synthesis screening tightened to de facto licence, two sequencing hubs exercising with disease agency, public-sector AI pilots cutting waits showcased for legitimacy.

Genome paper claimed model assistance could enable non-expert design of viable human pathogen — disputed but treated as step-change. Then H1 2028 a frontier-class open-weight system matching closed cutting edge on coding/research with bio-design and offensive cyber uplift spread irreversibly via hundreds of thousands of downloads. Containment abandoned for catch-next approach.

Commission tabled evaluation brake proposal under AI Act: vetted AI Office cell, third-party tests for EU deployment, draft intolerable-risk thresholds for bio-design/autonomous cyber — but unfunded, legally contested, no tests or thresholds yet.

Gigafactories/sovereignty package remained paper site lists, dragging capital amid contrast of working sensors vs paper factories, without institutional break. Journals quietly delayed AI-assisted clinical papers amid forensic checks.
```
